======= ANGEL2 =======
== Gene Information ==
* **Official Symbol**: ANGEL2
* **Official Name**: angel homolog 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=90806|90806]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q5VTE6|Q5VTE6]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ANGEL2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANGEL2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/619001|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: N/A
|Exo endo phos|
|3-UTR-mediated mRNA stabilization|
|3-5-exoribonuclease activity|
|RNA phosphodiester bond hydrolysis, exonucleolytic|
|mRNA stabilization|
|RNA stabilization|
|Cajal body|
|negative regulation of mRNA catabolic process|
|negative regulation of RNA catabolic process|
|mRNA 3-UTR binding|
|negative regulation of mRNA metabolic process|
|RNA phosphodiester bond hydrolysis|
|regulation of mRNA stability|
|regulation of RNA stability|
|regulation of mRNA catabolic process|
|negative regulation of cellular catabolic process|
|nucleic acid phosphodiester bond hydrolysis|
|negative regulation of mitotic cell cycle|
|negative regulation of catabolic process|
|regulation of mRNA metabolic process|
|posttranscriptional regulation of gene expression|
|negative regulation of cell cycle|
|regulation of mitotic cell cycle|
|regulation of cellular catabolic process|
|regulation of catabolic process|
|regulation of cell cycle|
|negative regulation of RNA metabolic process|
|negative regulation of nucleobase-containing compound metabolic process|
|RNA metabolic process|
|positive regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp189|Temozolomide 200μM R04 exp189]]|1.72|
|[[:results:exp474|CR131-b 0.005μM R08 exp474]]|2.08|
|[[:results:exp513|ONC212 0.15μM R08 exp513]]|2.3|
^Gene^Correlation^
|[[:human genes:g:gtpbp10|GTPBP10]]|0.46|
|[[:human genes:c:c12orf65|C12orf65]]|0.449|
|[[:human genes:c:c17orf89|C17orf89]]|0.429|
|[[:human genes:r:rnaseh1|RNASEH1]]|0.424|
|[[:human genes:m:mrpl15|MRPL15]]|0.423|
|[[:human genes:m:mrps5|MRPS5]]|0.415|
|[[:human genes:c:cox6c|COX6C]]|0.409|
|[[:human genes:w:wbscr16|WBSCR16]]|0.406|
|[[:human genes:g:gfm1|GFM1]]|0.401|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 9409
* **Expression level (log2 read counts)**: 5.9
{{:chemogenomics:nalm6 dist.png?nolink |}}